• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SH2-B家族成员在潜在负调控区域内的结合使JAK2维持在活性状态。

Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state.

作者信息

Kurzer Jason H, Saharinen Pipsa, Silvennoinen Olli, Carter-Su Christin

机构信息

Department of Molecular and Integrative Physiology, The University of Michigan Medical School, Ann Arbor, MI 48109-0622, USA.

出版信息

Mol Cell Biol. 2006 Sep;26(17):6381-94. doi: 10.1128/MCB.00570-06.

DOI:10.1128/MCB.00570-06
PMID:16914724
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1592834/
Abstract

The tyrosine kinase Janus kinase 2 (JAK2) transduces signaling for the majority of known cytokine receptor family members and is constitutively activated in some cancers. Here we examine the mechanisms by which the adapter proteins SH2-Bbeta and APS regulate the activity of JAK2. We show that like SH2-Bbeta, APS binds JAK2 at multiple sites and that binding to phosphotyrosine 813 is essential for APS to increase active JAK2 and to be phosphorylated by JAK2. Binding of APS to a phosphotyrosine 813-independent site inhibits JAK2. Both APS and SH2-Bbeta increase JAK2 activity independent of their N-terminal dimerization domains. SH2-Bbeta-induced increases in JAK2 dimerization require only the SH2 domain and only one SH2-Bbeta to be bound to a JAK2 dimer. JAK2 mutations and truncations revealed that amino acids 809 to 811 in JAK2 are a critical component of a larger regulatory region within JAK2, most likely including amino acids within the JAK homology 1 (JH1) and JH2 domains and possibly the FERM domain. Together, our data suggest that SH2-Bbeta and APS do not activate JAK2 as a consequence of their own dimerization, recruitment of an activator of JAK2, or direct competition with a JAK2 inhibitor for binding to JAK2. Rather, they most likely induce or stabilize an active conformation of JAK2.

摘要

酪氨酸激酶Janus激酶2(JAK2)可转导大多数已知细胞因子受体家族成员的信号,并且在某些癌症中持续激活。在此,我们研究衔接蛋白SH2 - Bβ和APS调节JAK2活性的机制。我们发现,与SH2 - Bβ一样,APS在多个位点与JAK2结合,并且与磷酸化酪氨酸813结合对于APS增加活性JAK2以及被JAK2磷酸化至关重要。APS与磷酸化酪氨酸813非依赖性位点的结合会抑制JAK2。APS和SH2 - Bβ均独立于其N端二聚化结构域增加JAK2活性。SH2 - Bβ诱导的JAK2二聚化增加仅需要SH2结构域,并且仅一个SH2 - Bβ与JAK2二聚体结合。JAK2突变和截短显示,JAK2中的氨基酸809至811是JAK2内更大调节区域的关键组成部分,很可能包括JAK同源性1(JH1)和JH2结构域内的氨基酸以及可能的FERM结构域。总之,我们的数据表明,SH2 - Bβ和APS激活JAK2并非因其自身二聚化、募集JAK2激活剂或与JAK2抑制剂直接竞争结合JAK2。相反,它们很可能诱导或稳定JAK2的活性构象。

相似文献

1
Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state.SH2-B家族成员在潜在负调控区域内的结合使JAK2维持在活性状态。
Mol Cell Biol. 2006 Sep;26(17):6381-94. doi: 10.1128/MCB.00570-06.
2
Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.SH2-bbeta的SH2结构域和N端区域对JAK2的差异性结合及调控
Mol Cell Biol. 2000 May;20(9):3168-77. doi: 10.1128/MCB.20.9.3168-3177.2000.
3
Kinase activation through dimerization by human SH2-B.人源SH2-B通过二聚化实现激酶激活。
Mol Cell Biol. 2005 Apr;25(7):2607-21. doi: 10.1128/MCB.25.7.2607-2621.2005.
4
YXXL motifs in SH2-Bbeta are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling.SH2-Bbeta中的YXXL基序被JAK2、JAK1和血小板衍生生长因子受体磷酸化,是膜皱襞形成所必需的。
J Biol Chem. 2003 Apr 4;278(14):11970-8. doi: 10.1074/jbc.M210765200. Epub 2003 Jan 27.
5
Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.鉴定SH2-bbeta为酪氨酸激酶Janus激酶2的一种强效细胞质激活剂。
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7172-7. doi: 10.1073/pnas.96.13.7172.
6
Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling.鉴定SH2-Bbeta作为参与生长激素信号传导的酪氨酸激酶JAK2的底物。
Mol Cell Biol. 1997 Nov;17(11):6633-44. doi: 10.1128/MCB.17.11.6633.
7
SH2-B family members differentially regulate JAK family tyrosine kinases.SH2-B家族成员对JAK家族酪氨酸激酶具有不同的调节作用。
J Biol Chem. 2002 Mar 8;277(10):8673-81. doi: 10.1074/jbc.M109165200. Epub 2001 Dec 18.
8
SH2-Bbeta is a Rac-binding protein that regulates cell motility.SH2-Bβ是一种调节细胞运动的Rac结合蛋白。
J Biol Chem. 2002 Mar 22;277(12):10669-77. doi: 10.1074/jbc.M111138200. Epub 2002 Jan 10.
9
Increased SH2-Bbeta content and membrane association in transgenic mice overexpressing GH.在过度表达生长激素的转基因小鼠中,SH2-Bβ含量增加且与膜结合。
J Endocrinol. 2005 May;185(2):301-6. doi: 10.1677/joe.1.05943.
10
Tyrosine 813 is a site of JAK2 autophosphorylation critical for activation of JAK2 by SH2-B beta.酪氨酸813是JAK2自身磷酸化的位点,对SH2-Bβ激活JAK2至关重要。
Mol Cell Biol. 2004 May;24(10):4557-70. doi: 10.1128/MCB.24.10.4557-4570.2004.

引用本文的文献

1
Massively parallel interrogation of human functional variants modulating cancer immunosurveillance.对调节癌症免疫监视的人类功能变异进行大规模平行检测。
Signal Transduct Target Ther. 2025 Mar 19;10(1):88. doi: 10.1038/s41392-025-02171-5.
2
2022 Cannon lecture: an ode to signal transduction: how the growth hormone pathway revealed insight into height, malignancy, and obesity.2022 年坎农讲座:向信号转导致敬:生长激素通路如何揭示身高、恶性肿瘤和肥胖的奥秘。
Am J Physiol Endocrinol Metab. 2023 Nov 1;325(5):E425-E437. doi: 10.1152/ajpendo.00265.2023. Epub 2023 Sep 6.
3
TGF-β1/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2/STAT3 and SHP2/Grb2 signaling pathways.TGF-β1/SH2B3 轴通过调节 JAK2/STAT3 和 SHP2/Grb2 信号通路调节肺癌细胞的抗失巢凋亡和 EMT。
Cell Death Dis. 2022 May 19;13(5):472. doi: 10.1038/s41419-022-04890-x.
4
The Molecular Genetics of Myeloproliferative Neoplasms.骨髓增殖性肿瘤的分子遗传学。
Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a034876. doi: 10.1101/cshperspect.a034876.
5
Crucial Role of the SH2B1 PH Domain for the Control of Energy Balance.SH2B1 PH 结构域在能量平衡控制中的关键作用。
Diabetes. 2019 Nov;68(11):2049-2062. doi: 10.2337/db19-0608. Epub 2019 Aug 22.
6
Phosphorylation of the Unique C-Terminal Tail of the Alpha Isoform of the Scaffold Protein SH2B1 Controls the Ability of SH2B1α To Enhance Nerve Growth Factor Function.支架蛋白 SH2B1 的α 同工型独特 C 末端尾部的磷酸化控制 SH2B1α 增强神经生长因子功能的能力。
Mol Cell Biol. 2018 Feb 27;38(6). doi: 10.1128/MCB.00277-17. Print 2018 Mar 15.
7
The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders.LNK/SH2B3 基因改变在骨髓增殖性肿瘤和其他血液系统疾病中的作用。
Leukemia. 2017 Aug;31(8):1661-1670. doi: 10.1038/leu.2017.139. Epub 2017 May 9.
8
SH2B1 regulation of energy balance, body weight, and glucose metabolism.SH2B1 调节能量平衡、体重和葡萄糖代谢。
World J Diabetes. 2014 Aug 15;5(4):511-26. doi: 10.4239/wjd.v5.i4.511.
9
The molecular regulation of Janus kinase (JAK) activation.Janus激酶(JAK)激活的分子调控
Biochem J. 2014 Aug 15;462(1):1-13. doi: 10.1042/BJ20140712.
10
JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms.JAK2突变体(例如,JAK2V617F)及其作为骨髓增殖性肿瘤药物靶点的重要性。
JAKSTAT. 2013 Jul 1;2(3):e25025. doi: 10.4161/jkst.25025. Epub 2013 May 14.

本文引用的文献

1
Differential role of SH2-B and APS in regulating energy and glucose homeostasis.SH2-B和APS在调节能量和葡萄糖稳态中的不同作用。
Endocrinology. 2006 May;147(5):2163-70. doi: 10.1210/en.2005-1313. Epub 2006 Feb 2.
2
The structural basis of Janus kinase 2 inhibition by a potent and specific pan-Janus kinase inhibitor.一种强效且特异性的泛Janus激酶抑制剂对Janus激酶2的抑制作用的结构基础。
Blood. 2006 Jan 1;107(1):176-83. doi: 10.1182/blood-2005-06-2413. Epub 2005 Sep 20.
3
Model for growth hormone receptor activation based on subunit rotation within a receptor dimer.基于受体二聚体内亚基旋转的生长激素受体激活模型。
Nat Struct Mol Biol. 2005 Sep;12(9):814-21. doi: 10.1038/nsmb977. Epub 2005 Aug 21.
4
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice.鉴定SH2-B为小鼠瘦素敏感性、能量平衡和体重的关键调节因子。
Cell Metab. 2005 Aug;2(2):95-104. doi: 10.1016/j.cmet.2005.07.004.
5
Identification of an acquired JAK2 mutation in polycythemia vera.真性红细胞增多症中获得性JAK2突变的鉴定。
J Biol Chem. 2005 Jun 17;280(24):22788-92. doi: 10.1074/jbc.C500138200. Epub 2005 Apr 29.
6
A gain-of-function mutation of JAK2 in myeloproliferative disorders.骨髓增殖性疾病中JAK2的功能获得性突变。
N Engl J Med. 2005 Apr 28;352(17):1779-90. doi: 10.1056/NEJMoa051113.
7
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.真性红细胞增多症、原发性血小板增多症和伴有骨髓纤维化的骨髓化生中酪氨酸激酶JAK2的激活突变。
Cancer Cell. 2005 Apr;7(4):387-97. doi: 10.1016/j.ccr.2005.03.023.
8
Kinase activation through dimerization by human SH2-B.人源SH2-B通过二聚化实现激酶激活。
Mol Cell Biol. 2005 Apr;25(7):2607-21. doi: 10.1128/MCB.25.7.2607-2621.2005.
9
Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.Lnk抑制红细胞生成以及Epo依赖的JAK2激活和下游信号通路。
Blood. 2005 Jun 15;105(12):4604-12. doi: 10.1182/blood-2004-10-4093. Epub 2005 Feb 10.
10
The Janus kinases (Jaks).酪氨酸激酶(Jaks)。
Genome Biol. 2004;5(12):253. doi: 10.1186/gb-2004-5-12-253. Epub 2004 Nov 30.